FDA to discuss imatinib for PAH

FDA's Cardiovascular and Renal Drugs Advisory Committee will meet on Sept. 14 to discuss an NDA from Novartis AG (NYSE:NVS; SIX:NOVN) for imatinib to treat pulmonary arterial hypertension (PAH). The P...